molecules Molecules Molecules Molecules 1420-3049 MDPI 10.3390/molecules17089790 molecules-17-09790 Article Synthesis of Disaccharides Containing 6-Deoxy-α-L-talose as Potential Heparan Sulfate Mimetics Fairweather Jon K. Liu Ligong † Karoli Tomislav † Ferro Vito ‡ * Drug Design Group, Progen Pharmaceuticals Ltd, Brisbane QLD 4076, Australia

Current address: Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD 4072, Australia.

Current address: School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD 4072, Australia.

 Author to whom correspondence should be addressed; Email: v.ferro@uq.edu.au; Tel.: +61-7-3346-9598; Fax: +61-7-3365-4299. 15 08 2012 08 2012 17 8 9790 9802 28 06 2012 05 08 2012 09 08 2012 © 2012 by the authors; licensee MDPI, Basel, Switzerland. 2012

This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).

A 6-deoxy-α-L-talopyranoside acceptor was readily prepared from methyl α-L-rhamnopyranoside and glycosylated with thiogalactoside donors using NIS/TfOH as the promoter to give good yields of the desired α-linked disaccharide (69–90%). Glycosylation with a 2-azido-2-deoxy-D-glucosyl trichloroacetimidate donor was not completely stereoselective (α:β = 6:1), but the desired α-linked disaccharide could be isolated in good overall yield (60%) following conversion into its corresponding tribenzoate derivative. The disaccharides were designed to mimic the heparan sulfate (HS) disaccharide GlcN(2S,6S)-IdoA(2S). However, the intermediates readily derived from these disaccharides were not stable to the sulfonation/deacylation conditions required for their conversion into the target HS mimetics.

 disaccharides heparan sulfate mimetics fibroblast growth factors 1. Introduction

The fibroblast growth factors FGF-1 and FGF-2 are heparan sulfate (HS)-binding proteins that play key roles in tumor angiogenesis, a critically important process in tumor growth and development [1,2]. They promote angiogenesis by binding with HS and their receptors (FGFRs) to form a ternary HS:FGF:FGFR complex which leads to receptor dimerization/activation and subsequent initiation of cell signaling [3]. Inhibiting angiogenesis by blocking ternary complex formation with HS mimetics is thus a promising strategy for the development of anticancer drugs [4,5,6] without the side effects sometimes associated with other antiangiogenic therapies [7].

A number of studies have described the synthesis of specific HS or HS-like oligosaccharides to interact with FGF-1 or FGF-2 [8,9,10,11] in order to obtain information about structural requirements for HS-FGF binding and activation. Despite much recent progress [12,13,14], the synthesis of native HS oligosaccharides remains a difficult and labour-intensive exercise and has thus lead to interest in less synthetically challenging oligosaccharide mimetics as FGF antagonists [10,15,16,17]. As part of a program aimed at the development of angiogenesis inhibitors, we recently described [18,19] the synthesis of simple disaccharides such as 2–6 which mimic the HS disaccharide GlcN(2S,6S)-IdoA(2S) (1, Figure 1), postulated from X-ray crystallographic analyses as a minimal HS consensus sequence for FGF binding [20]. The compounds were designed to maintain the α-(1→4) linkage between the two monosaccharide units and the spatial orientation of the two key sulfo groups [GlcN(2S) and IdoA(2S)]. The conformationally flexible disaccharides 2–4 were designed to mimic this known property [21,22] of IdoA residues. Disaccharides 5 and 6, on the other hand, were designed to investigate the other extreme: a locked 1C4 conformation. Molecular docking calculations indicated that the predicted locations of disaccharide sulfo groups in the binding site of FGF-1 and FGF-2 were consistent with the positions observed for co-crystallized heparin-derived oligosaccharides. These studies suggest that it may be possible to mimic HS oligosaccharides with simpler structures.

Structures of the GlcN(2S,6S)-IdoA(2S) disaccharide sequence 1, which represents a minimal consensus sequence for FGF:HS binding [20], conformationally flexible mimetics 2–4 [18], conformationally locked mimetics 5 and 6 [19], and proposed disaccharides of intermediate flexibility 7–10.

In order to extend the above investigations we herein describe the design and synthesis of simple disaccharides with intermediate conformational flexibility compared with 2–6, which once sulfated, could mimic disaccharide 1.

 2. Results and Discussion

The previously synthesized disaccharides 2–6 were designed to mimic the essential features of 1, in particular the α-(1→4) linkage between the two monosaccharide units and the spatial orientation of the two key sulfo groups [GlcN(2S) and IdoA(2S)], with the assumption that N-sulfo groups could be interchanged with O-sulfo groups and vice versa. The disaccharides were prepared by the glycosylation of suitable monosaccharide acceptors (as IdoA mimics) with non-participating C2-protected glycosyl donors such as D-thiogalactosides 11 and 12 or the 2-azido-glucosyl imidate 13 (Figure 2), to favour the stereoselective formation of the desired α-(1→4) linkage. Disaccharides 2–4 are composed of a 2-O-sulfated D-Gal α(1→4)-linked to a polysulfated β-D-glucoside or xyloside. Polysulfation of β-D-glucosides or xylosides confers conformational flexibility upon this monosaccharide residue [23,24], confirmed by 1H-NMR spectroscopy, thus mimicking the conformational flexibility of IdoA. Disaccharides 5–6 on the other hand are composed of a D-glucosamine-N-sulfate α(1→4)-linked to a 1,6-anhydro-2-amino glucose. The latter is locked in the 1C4 conformation, mimicking the conformation of IdoA as found in some crystal structures of heparin oligosaccahrides bound to FGF [25,26].

Glycosyl donors (11–13) and 6-deoxy-L-taloside acceptor (14).

In order to extend the above studies, it was decided to investigate IdoA mimics with intermediate degrees of conformational flexibility. The 6-deoxy-L-taloside 14 was thus selected as a potential glycosyl acceptor because, like the majority of the L-sugars, it was expected to adopt the 1C4 conformation in solution but not be strictly held in this conformation like 5 and 6. It was anticipated that the use of 14 would, after deprotection and sulfonation, lead to target disaccharides such as 7–10. In addition to the desired 2-O-sulfate, an additional sulfate at O-3 could provide additional electrostatic interactions with the target proteins. Acceptor 14 was thus prepared in a straightforward manner from methyl α-L-rhamnopyranoside 15 [27], as outlined in Scheme 1. Triol 15 was treated with 2,2-dimethoxypropane and toluenesulfonic acid as catalyst to give the isopropylidene 16 which was subsequently oxidised with Dess-Martin periodinane to the ketone 17 in good yield (70%, 2 steps). Stereoselective reduction with sodium borohydride in methanol gave exclusively the 6-deoxy-α-L-taloside 18 which was converted into the diol 20 in moderate yield (54%, 3 steps) via allylation at C4 followed by toluenesulfonic acid catalysed methanolysis of the isopropylidene group. Diol 20 was then benzylated (NaH/benzyl bromide, 87%) and de-O-allylated with PdCl2 in methanol at reflux to afford the alcohol 14 in excellent yield (95%), ready for use in the glycosylation studies.

Glycosylation of acceptor 14 with methyl thiogalactoside donor 11 in dichloromethane at −20 °C with NIS/TfOH as the promoter was very rapid and gave the disaccharide 22 in high yield (90%) following purification by flash chromatography (Scheme 2). Analysis of the 1H-NMR spectrum of 22 confirmed the presence of the newly formed α-glycosidic linkage (doublet at 5.77 ppm, J1,2 = 3.6 Hz), and that the L-taloside ring remained in the desired 1C4 conformation (3J = 2.4–3.2 Hz). Interestingly the use of the homologous ethyl donor 12 resulted in a less clean reaction and only gave 22 in a still acceptable 69% isolated yield after flash chromatography.

molecules-17-09790-scheme1_Scheme 1

Synthesis of 6-deoxy-L-taloside acceptor 14.

 molecules-17-09790-scheme2_Scheme 2

Assembly of D-Gal-L-Tal disaccharide and attempted conversion into sulfated derivatives.

Attention was then turned towards conversion of 22 into the sulfated target disaccharides 7 and 8. Unfortunately, the compounds in this series proved to be unusually unstable to the standard transformations [18,19] used to successfully prepare disaccharides 2–6 (Scheme 2). Hydrogenolytic debenzylation of disaccharide 22 was hampered by apparent poisoning of the palladium catalyst by trace sulfur-containing impurities from the glycosylation step. However, by replacing the catalyst four times during reaction, and in the presence of glacial acetic acid, triol 23 was obtained in low yield (33%), but good purity after flash chromatography. Subsequent attempted sulfonation with concomitant deacetylation of 23 (SO3.Me3N followed by aqueous 3 M NaOH) gave rise to complex mixtures from which no pure product could be isolated by the chromatographic procedures previously used [18,19] (size exclusion chromatography on Bio-Gel P-2). It is known that sulfonation of carbohydrate polyols with sulfur trioxide-amine complexes can induce cleavage of acid labile groups and glycosidic linkages [28]. Evidently disaccharide 23 is not stable to these harsh conditions. In attempts to prepare the trimethyl derivative, both the Zemplén deacetylation/methylation and hydrogenolysis steps were low yielding (29–46% and 55%, respectively). The former caused significant degradation and in one case resulted in the isolation of the monosaccharide 27 as the dominant product (71%). Cleavage of glycosidic bonds under basic conditions in the presence of atmospheric oxygen is known [29,30], and could account for the degradation seen here, but it is unclear why these disaccharides are so sensitive compared with the earlier series. Attempted sulfonation of the small amounts of available 26 produced also gave rise to complex mixtures from which the desired products could not be isolated.

Attention was then turned to the alternative disaccharide series using imidate 13 as the glycosyl donor (Scheme 3). Following literature precedent [31], TBDMSOTf was selected as the promoter for the glycosylation of 14 with donor 13. The reaction proceeded rapidly in 1,2-dichloroethane at −20 °C (10 min, then→rt over 20 min), however, it was not completely stereoselective and resulted in an inseparable mixture of α and β anomers 28 (α:β = 6:1). The crude mixture was therefore deacetylated under Zemplén conditions (NaOMe in MeOH) and the crude triol 29 then benzoylated with benzoyl chloride in pyridine. The resultant mixture of benzoates was separable by careful column chromatography from which the desired α-linked disaccharide 30 was isolated in 60% overall yield along with the β-anomer 31 (10%).

molecules-17-09790-scheme3_Scheme 3

Synthesis of D-Glc-L-Tal disaccharides.

We were not able to transform disaccharide 30 into the desired sulfated products 9 or 10 (Scheme 4). Disaccharide 30 was subjected to catalytic transfer hydrogenation (Pearlman’s catalyst/ammonium formate) to presumably give the crude amine. However, attempted sulfonation only gave a complex mixture of products and 1H-NMR analysis indicated some loss of benzoates. The mixture was subjected to standard benzoylation conditions (excess benzoyl chloride/pyridine) but this did not result in simplification of the mixture and no pure products could be recovered. Compound 30 was subjected to the Zemplén and methylation procedures to give the trimethyl derivative 32 in moderate yield (69% over 2 steps). However, when this compound was subjected to the same azide reduction/sulfonation procedure as above, once again a complex mixture resulted from which no identifiable products were isolated.

molecules-17-09790-scheme4_Scheme 4

Attempted conversion into sulfated derivatives.

 3. Experimental General

1H-NMR spectra were recorded at 400 MHz for 1H, 100 MHz for 13C in deuteriochloroform (CDCl3) with residual CHCl3 (1H, δ 7.26) employed as internal standard, at ambient temperatures (298 K) unless specified otherwise. Where appropriate, analysis of 1H-NMR spectra was aided by gCOSY experiments. Flash chromatography was performed on Merck silica gel (40–63 μm) under a positive pressure with the specified eluants. All solvents used were of analytical grade. The progress of the reactions was monitored by TLC using commercially prepared Merck silica gel 60 F254 aluminium-backed plates. Compounds were visualized by charring with 5% sulfuric acid in MeOH and/or by visualization under ultraviolet light. The term ‘workup’ refers to dilution with water, extraction into an organic solvent, sequential washing of the organic extract with aq. 1 M HCl (where appropriate), saturated aq. NaHCO3 and brine, followed by drying over anhydrous MgSO4, filtration and evaporation of the solvent by means of a rotary evaporator at reduced pressure and where appropriate, extensive drying of the residue at <1 mmHg.

Attempted sulfonation. The polyol was dissolved in anhydrous DMF (0.04 M) and sulfur trioxide pyridine complex (2 eq. per hydroxyl) or sulfur trioxide trimethylamine complex (3 eq. per hydroxyl) was added. The mixture was stirred at 60 °C under a nitrogen (6–16 h), cooled (0 °C), treated with MeOH (2 mL) and then made basic to pH ≥ 9 by addition of 3 M NaOH solution. The mixture was filtered and evaporated to dryness and the residue was purified by size exclusion chromatography (Bio-Gel P-2, 5 × 100 cm, 2.8 mL/min, 0.1 M NH4HCO3, 2.8 min per vial). The fractions were analyzed for carbohydrate content by TLC (charring) or the 1,9-dimethylmethylene blue test [32] and for purity by CE [33].

Attempted sulfonation/deacylation. The polyol was sulfonated according to the general procedure for sulfonation, however, the residue obtained from evaporation of basified (pH = 9) crude mixture was redissolved in 3 M NaOH (0.16 M) and stirred at rt (o/n) before purification.

Ethyl 3,4,6-tri-O-acetyl-2-O-benzyl-1-thio-β-D-galactopyranoside 12. The title compound was prepared from ethyl 1-thio-β-D-galactopyranoside in an analogous fashion to the methyl thiogalactoside 11 according to the procedure of Pozsgay [34]. Flash chromatography (hexanes/EtOAc 6:1→2:1) gave 12 as a colourless oil (Rf = 0.20, hexanes/EtOAc 4:1). 1H-NMR: δ 7.35-7.23 (m, 5H, Ph), 5.37 (dd, 1H, J3,4 = 3.2, J4,5 = 1.2, H4), 4.98 (dd, 1H, J2,3 = 9.6, H3), 4.83, 4.57 (ABq, 2H, JA,B = 10.8, CH2Ph), 4.52 (d, 1H, J1,2 = 9.6, H1), 4.13 (dd, 1H, J6a,6b = 11.2, J5,6a = 7, H6a), 4.05 (dd, 1H, J5,6b = 6.4, H6b), 3.84 (ddd, 1H, H5), 3.62 (dd, 1H, H2), 2.82-2.68 (m, 2H, SCH2), 2.09 (s, 3H, Ac), 2.00 (s, 3H, Ac), 1.90 (s, 3H, Ac), 1.30 (t, 3H, J = 7.6, CH3).

Methyl 6-deoxy-2,3-O-isopropylidene-α-L-lyxo-hexopyran-4-uloside 17. (A) p-TsOH.H2O (100 mg) was added to a mixture of methyl α-L-rhamnopyranoside (15) [27] (1.45 g, 8.1 mmol) in 2,2-dimethoxypropane (10 mL) and the combined mixture stirred (rt, 20 min). Et3N (100 μL) was added to neutralise the reaction mixture and the solvent was evaporated. The residue was dissolved (EtOAc) and subjected to workup yielding, presumably, the acetal 16 [35] as a colourless oil. This was used for the next step without further purification. (B) Dess-Martin periodinane (3.80 g, 8.9 mmol) was added to the crude alcohol 16 [from (A) above] in 1,2-dichloroethane and the combined mixture heated (70 °C, 1 h). The mixture was cooled (rt) and then diluted (CHCl3) prior to workup including pre-treatment with Na2S2O3 (2 M). The residue was subjected to flash chromatography (EtOAc/hexanes 1:9→3:7) to give the ketone 17 [36] as a pale yellow oil (1.24 g, 70%, 2 steps). This was used for the next step without further characterisation.

Methyl 4-O-allyl-6-deoxy-α-L-talopyranoside 20. (A) NaBH4 (200 mg, 5.0 mmol) was added portion-wise to a stirred solution of the ketone 17 (1.24 g, 5.7 mmol) in MeOH (60 mL). The mixture was treated with AcOH (10% aq.) dropwise to destroy the excess reducing agent and the solvent evaporated. The residue was subjected to workup (EtOAc) yielding the alcohol 18 as a pale yellow oil. This was used in the next reaction without further purification. (B) The alcohol 18 [from (A) above] in DMF (2 mL) was added dropwise to a stirred suspension of pre-washed (hexane) NaH (560 mg of 50% oil suspension, 11.4 mmol) in DMF (15 mL) and the combined mixture stirred (0 °C→rt, 30 min). The mixture was then cooled (0 °C) and allyl bromide (735 μL, 8.5 mmol) was introduced and stirring continued (0 °C→rt, o/n). The mixture was cooled (0 °C), MeOH (3 mL) was added and stirring continued (5 min) prior to evaporation of the solvent. The residual oil was subjected to workup (EtOAc) to yield the acetal 19 as a pale yellow oil (1.12 g). This was used for the next reaction without further purification. (C) A mixture of the acetal 19 [from (B) above] and p-TsOH.H2O (100 mg) in MeOH (20 mL) and MeCN (20 mL) was heated under reflux (1 h). The mixture was cooled (rt) and Et3N (100 μL) was added prior to evaporation of the solvent. The residue was subjected to workup (EtOAc) and flash chromatography (EtOAc/hexanes 1:4→2:3) to yield the diol 20 as a colourless oil (668 mg, 54%, 3 steps). 1H-NMR: δ 1.26 (d, 3H, J5,6 6.4 Hz; H6), 3.33 (s, 3H, OMe), 3.46–3.48 (m, 1H, H2), 3.62 (br s, 1H, H4), 3.75 (dd, 1H, J2,3 = J3,4 = 3.2 Hz, H3), 3.79-3.85 (m, 1H H5), 4.12–4.26 (m, 2H, OCH2), 4.71 (s, 1H, H1), 5.15–5.27 (m, 2H, CH=CH2), 5.84–5.93 (m, 1H, CH=CH2); 13C-NMR (CDCl3, 100 MHz): δ 17.1, 55.2, 65.9, 66.7, 70.9, 75.6, 81.3, 102.2, 118.0, 134.3.

Methyl 2,3-di-O-benzyl-6-deoxy-α-L-talopyranoside 14. (A) The diol 20 (110 mg, 0.50 mmol) in DMF (1 mL) was added dropwise to a stirred suspension of pre-washed (hexane) NaH (500 mg of 50% oil suspension, 10 mmol) in DMF (5 mL) and the combined mixture stirred (0 °C→rt, 30 min). The mixture was then cooled (0 °C) and benzyl bromide (250 μL), 2.0 mmol) was introduced and stirring continued (0 °C→rt, o/n). The mixture was cooled (0 °C) and MeOH (3 mL) was added with continued stirring (5 min) prior to evaporation of the solvent. The residual oil was subjected to rapid silica filtration (10–40% EtOAc/hexanes) to yield, presumably, the dibenzyl ether 21 as a pale yellow oil (174 mg, 87%). This was used for the next reaction without further characterisation or purification. (B) A mixture of the allyl ether 21 (170 mg, 0.43 mmol) and PdCl2 (20 mg) in MeOH (15 mL) was heated under reflux (1 h). The solvent was evaporated and the residue subjected to flash chromatography (EtOAc/hexanes 1:9→3:7) to yield the alcohol 14 as a pale yellow oil (146 mg, 95%). 1H-NMR: δ 1.30 (s, 3 H, H6), 3.29 (s, 3 H, OMe), 3.65 (dd, 1 H, J2,3 = J3,4 = 3.2 Hz, H3), 3.69–3.75 (m, 3 H, H2, H4, H5), 4.51, 4.71 (ABq, JA,B = 12.0 Hz, CH2Ph), 4.68, 4.79 (ABq, JA,B = 11.9 Hz, CH2Ph), 4.72 (d, 1 H, J1,2 = 0.8 Hz, H1).

Methyl 3,4,6-tri-O-acetyl-2-O-benzyl-α-D-galactopyranosyl-(1→4)-2,3-di-O-benzyl-6-deoxy-α-L-talo-pyranoside 22. From donor 11: A mixture of the alcohol 14 (128 mg, 357 μmol), thioglycoside 11 (183 mg, 428 μmol) and freshly activated, powdered 3 Å mol sieves (500 mg) in dry CH2Cl2 (10 mL) was stirred at −30 °C for 20 min before adding NIS (125 mg, 556 μmol, 1.3 eq.) and TfOH (1 drop). Stirring was continued at −30 °C until the reaction was complete by TLC (~1.5 h) before Et3N (584 μL, 424 mg, 4.2 mmol, 7.5 eq.) was added. Evaporation onto silica gel and flash chromatography (EtOAc/hexanes 1:3→9:11) gave disaccharide 22 as a colourless film (238 mg, 90%; Rf = 0.28, hexanes/EtOAc = 1:1). 1H-NMR: δ 7.1-7.4 (m, 15H, 3 × Ph), 5.77 (d, 1H, J1,2 = 3.6 Hz, H1II), 5.46 (dd, 1H, J3,4 = 3.4, J4,5 = 1.3 Hz, H4II), 5.41 (dd, 1H, J2,3 = 10.4 Hz, H3II), 4.83 (d, 1H, J1,2 = 2.4 Hz, H1I), 4.49-4.72 (m, 6H, PhCH2), 4.27 (ddd, 1H, H5II), 4.11 (dd, 1H, J6a,6b = 11.4, J5,6b = 7.0, H6bII), 4.04 (dd, 1H, J5,6a = 6.4, H6aII), 3.95 (m, 1H, H5I), 3.94 (m, 1H, H4I), 3.83 (dd, 1H, H2II), 3.80 (dd, 1H, J2,3~3,4 = 3.2, H3I), 3.59 (dd, 1H, J1,2+2,3 = 2.8, H2I), 3.33 (s, 3H, OMe), 2.05 (s, 3H, Ac), 2.04 (s, 3H, Ac), 1.96 (s, 3H, Ac), 1.42 (d, 3H, J5,6 = 6.4, H6I); 13C NMR: δ 170.4, 170.0, 169.8, 138.3(2), 138.3(0), 138.1, 128.3, 128.1, 127.9, 127.8, 127.5, 127.4, 127.3(2), 127.2(8), 127.1, 99.0, 96.4, 77.3, 73.2, 72.3, 72.2, 72.1, 71.5, 71.2, 69.1, 68.4, 67.0, 66.3, 62.1, 55.0, 20.7, 20.6, 20.5, 17.0. From donor 12: The alcohol 14 (95 mg, 265 μmol), thioglycoside 12 (117 mg, 265 μmol) and freshly activated, powdered 3 Å mol sieves (350 mg) were subjected to the above NIS glycosylation conditions using 78 mg (345 μmol, 1.3 eq.) of NIS. Flash chromatography (EtOAc/hexanes 1:4→1:1) gave the pure α-anomer 22 (134 mg, 69%).

Methyl 3,4,6-tri-O-acetyl-α-D-galactopyranosyl-(1→4)-6-deoxy-α-L-talopyranoside 23. To a solution of 22 (120 mg, 163 μmol) in MeOH (5 mL) was added Pd/C (5%, 20 mg). The suspension was stirred (5 min) then filtered and additional Pd/C (5%, 20 mg) was added along with glacial acetic acid (20 μL) and the suspension was stirred overnight under hydrogen. The catalyst was replaced and the hydrogen was refilled with stirring overnight two more times before the suspension was filtered and subjected to flash chromatography (EtOAc/hexanes 3:2→7:3) to give the triol 23 (25 mg, 33%) as a colourless film. 1H-NMR (200 MHz, CDCl3): 5.44 (d, 1H, J3,4 = 3.1, H4II), 5.33 (d, 1H, J1,2 = 4.2, H1II), 5.09 (dd, 1H, J2,3 = 10.6, H3II), 4.73 (br s, 1H, H1I), 4.43 (t, 1H, J5,6 = 6.3, H5II), 4.11 (dd, 1H, H2II), 4.06 (app d, 2H), 3.8–4.0 (m, 3H), 3.65–3.71 (m, 1H), 3.35 (s, 3H, OMe), 3.3–3.5 (br s, 3H, OH), 2.12 (s, 3H, AcO), 2.03 (s, 3H, AcO), 2.02 (s, 3H, AcO), 1.32 (d, 3H, J5,6 = 6.6, H6I).

Methyl 3,4,6-tri-O-methyl-2-O-benzyl-α-D-galactopyranosyl-(1→4)-2,3-di-O-benzyl-6-deoxy-α-L-talo-pyranoside (25). A sliver of sodium was added to a solution of triacetate 22 (110 mg) in MeOH (10 mL) before stirring overnight. The solution was neutralised with resin (AG-50X8 H+), filtered and evaporated. DMF (10 mL), sodium hydride (30 mg, 60% in oil) and methyl iodide (50 μL) were added and the mixture was stirred overnight before it was quenched (ice), evaporated and subjected to flash chromatography (EtOAc/hexanes 3:7→3:2) to give 25 (45 mg, 46%) as a colourless film (Rf = 0.08, hexanes/EtOAc = 65:35). 1H-NMR: δ 7.0–7.3 (m, 15H, 3 × Ph), 5.50 (br d, 1H, J = 3.1, H1II), 4.78 (d, 1H, J = 3.2, H1I), 4.4–4.7 (m, 6H, PhCH2), 3.9–4.0 (m, 2H), 3.82 (br t, 1H, J = 2.8), 3.81 (dd, 1H, J = 3.7, 10, H2II), 3.64–3.76 (m, 3H), 3.503 (s, 3H, OMe), 3.499 (s, 3H, OMe), 3.48–3.52 (m, 2H), 3.43 (dd, 1H, J = 6.2, 9.5), 3.34 (s, 3H, OMe), 3.29 (s, 3H, OMe), 1.37 (d, 3H, J = 6.7, H6I).

In a separate experiment, following the above deacetylation and benzylation procedures, the triacetate 22 (67 mg, 90.9 μmol) was converted to trimethyl ether 25 as a minor product (17 mg, 29%, Rf = 0.08, hexanes/EtOAc = 65:35). The major fraction was the decomposed by-product methyl 2,3-di-O-benzyl-4-O-methyl-6-deoxy-α-L-talopyranoside 27 (colourless gum, 24 mg, 71%, Rf = 0.32, hexanes/EtOAc 65:35). 1H-NMR: δ 7.42–7.24 (m, 10H, 2 × Ph), 4.86, 4.72 (ABq, 2H, JA,B = 12.8, PhCH2), 4.76 (d, 1H, J = 1.6, H1), 4.53 (s, 2H, PhCH2), 3.85–3.80 (m, 1H), 3.68–3.64 (m, 2H), 3.66 (s, 3H, CH3O), 3.39 (m, 1H), 3.30 (s, 3H, CH3O), 1.33 (d, 3H, J = 6.4, CH3).

Methyl 3,4,6-tri-O-methyl-α-D-galactopyranosyl-(1→4)-6-deoxy-α-L-talopyranoside 26. 5% Palladium on activated charcoal (10 mg) and acetic acid (200 μL) were added to a solution of tribenzyl ether 25 (40 mg, 61 μmol) in MeOH (10 mL). The reaction flask was evacuated and refilled with hydrogen three times before the mixture was stirred under hydrogen overnight. The mixture was then filtered, evaporated and subjected to flash chromatography (EtOAc) to yield of triol 26 (13 mg, 55%) as a colourless oil. 1H-NMR: δ 5.26 (d, 1H, J = 4.2, H1II), 4.76 (d, 1H, J = 1.4, H1I), 4.10-4.15 (m, 2H), 3.93 (dq, 1H, J = 0.7, 6.5, H5I), 3.82 (t, 1H, J = 3.4), 3.77–3.79 (m, 1H), 3.70 (dd, 1H, J = 1.4, 3.3, H2I), 3.55 (s, 3H, OMe), 3.52–3.58 (m, 1H), 3.50 (s, 3H, OMe), 3.42–3.47 (m, 2H), 3.38 (s, 3H, OMe), 3.36 (s, 3H, OMe), 1.32 (d, 3H, J = 6.8, H6I).

Methyl 2-azido-3,4,6-tri-O-benzoyl-2-deoxy-α-D-glucopyranosyl-(1→4)-2,3-di-O-benzyl-6-deoxy-α-L-talopyranoside 30. (A) A mixture of the imidate [19] 13 (291 mg, 0.66 mmol) and alcohol 14 (157 mg, 0.44 mmol) in 1,2-DCE (5 mL) was stirred in the presence of activated mol. sieves (300 mg of 3 Å powder) under an atmosphere of argon (rt, 30 min) and then cooled (−20 °C) with continued stirring (10 min). TBDMSOTf (30 μL, 0.132 mmol) was introduced dropwise and the mixture was warmed (−20 °C→0 °C, 20 min). Et3N (100 μL) was introduced and the mixture was filtered and evaporated. The residue was subjected to workup (EtOAc) and flash chromatography (EtOAc/hexanes 1:9→2:3) to yield a fraction presumed to contain the disaccharide product 28 as a pale yellow oil (301 mg). 1H-NMR analysis indicated that a monosaccharide component was also present in the mixture. This residue was co-evaporated (2 × 10 mL CH3CN) and used in the next reaction without further purification or characterisation. (B) Na (a small piece) was added to a solution of the mixture from (A) (above) (0.44 mmol, max.) in MeOH (4 mL) and the combined mixture stirred (rt, 1 h). The mixture was evaporated and neutralised by the addition of Dowex 50X8 resin (H+ form), filtered and the filtrate evaporated. The residue was subjected to workup (EtOAc) and flash chromatography (EtOAc/hexanes 1:1→9:1) to yield a colourless oil (210 mg). This residue was co-evaporated (2 × 10 mL CH3CN) and used in the next reaction without further purification or characterisation. (C) BzCl (306 μL, 2.64 mmol) was added to a solution of the mixture from (A) (above) (29) (0.44 mmol, max.) and pyridine (2 mL) in 1,2-DCE (4 mL) and the combined mixture stirred (rt, o/n). The mixture was cooled (0 °C) and MeOH (2 mL) was introduced with continued stirring (0 °C→rt, 2 min) before evaporation and co-evaporation (toluene) of the solvent. The residue was subjected to workup (EtOAc) and flash chromatography (EtOAc/hexanes 1:9→3:7) to yield two compounds. Firstly, the α-linked disaccharide (30) was obtained as a colourless oil (217 mg, 60%, 3 steps). 1H-NMR: δ 1.48 (d, 3 H, J5,6 = 6.6 Hz, H6I), 3.31 (s, 3H, OCH3), 3.40 (dd, 1H, J1,2 = 3.7, J2,3 = 10.6 Hz, H2II), 3.64–3.65 (m, 1H, H2I), 3.73 (m, 1H, H3I), 3.88–3.95 (m, 1H, H5I), 4.05–4.07 (m, 1H, H4I), 4.35 (ddd, 1H, J4,5 = 10.2, J5,6a = 3.3, J5,6b = 5.8 Hz, H5II), 4.37, 4.61 (ABq, JA,B = 11.6 Hz; CH2Ph), 4.50 (dd, 1H, J6a,6b = 12.0 Hz, H6bII), 5.58 (dd, 1H, H6aII), 4.67, 4.77 (ABq, JA,B = 12.7 Hz, CH2Ph), 4.82 (d, 1H, J1,2 = 1.6 Hz, H1I), 5.24 (dd, 1H, J3,4 = 9.5, J4,5 = 10.1 Hz, H4II), 5.99 (dd, 1H, J2,3 = 10.7, J3,4 = 9.3 Hz, H3II), 6.14–6.15 (d, 1H, J1,2 = 4.0 Hz, H1II), 7.20–7.54, 7.90–7.99 (2 m, 25H, 5 × Ph); 13C-NMR: δ 17.6, 55.2, 61.8, 63.7, 66.9, 68.3, 70.5, 70.6, 70.6, 74.5, 96.3, 99.9, 127.7, 128.2, 128.4, 128.5, 128.5, 128.6, 128.6, 129.0, 129.5, 129.8, 129.9, 130.0, 130.1, 133.3, 133.4, 133.6, 136.3, 138.8, 165.6, 165.7, 166.3.

Next, the β-linked disaccharide (31) was obtained as a colourless oil (36 mg, 10%, 3 steps). 1H-NMR: δ 1.46 (d, 3H, J5,6 = 6.6 Hz, H6I), 3.33 (s, 3H, OMe), 3.53 (t, 1H, J1,2 = J 2,3 = 3.2 Hz, H2I), 3.70–3.75 (m, 1H, H2II), 3.85–3.93, 3.97–4.01 (2 m, 4H, H3I, H4I, H5I, H5II), 4.29 (dd, 1H, J5,6a = 5.3, J6a,6b = 12.2 Hz, H6aII); 4.44 (dd, 1H, J5,6b = 3.3, H6bII), 4.54, 4.73 (ABq, JA,B = 11.9 Hz, CH2Ph), 4.65 (d, 1H, J1,2 = 8.0 Hz, H1II), 4.72, 4.76 (ABq, JA,B = 12.7 Hz, CH2Ph), 4.77 (d, 1H, J1,2 = 3.5 Hz, H1I), 5.44–5.51 (m, 2H, H3II, H4II), 7.20–7.51, 7.83–7.94 (2 m, 25H, 5 × Ph).

Methyl 3,4,6-tri-O-methyl-2-azido-2-deoxy-α-D-glucopyranosyl-(1→4)-2,3-di-O-benzyl-6-deoxy-α-L-talopyranoside 32. Tribenzoate 30 (110 mg, 128 µmol) was subjected to the Zemplén and methylation procedures (as described above for the preparation of 25) with MeI (82 mg, 582 µmol). Flash chromatography (hexanes→EtOAc/hexanes 1:4) gave the trimethyl derivative 32 (52 mg, 69%, 2 steps) as a colourless oil. 1H-NMR: δ 7.42–7.22 (m, 10H, 2 × Ph), 5.73 (d, 1H, J = 3.7, H1II), 4.84 (d, 1H, J = 2.0, H1I), 4.82, 4.77 (ABq, 2H, J = 12.6, CH2Ph), 4.58, 4.54 (ABq, 2H, J = 11.9, CH2Ph), 3.95–3.93 (m, 1H), 3.90 (dt, 1H, J = 2.0, 6.7, H5I), (s, 3H, OMe), 3.76–3.57 (m, 6H), 3.65, 3.55, 3.42, 3.31 (4 × s, 4 × 3H, OMe), 3.28–3.21 (m, 2H), 1.34 (d, 3H, J = 6.5, H6I).

 4. Conclusions

In conclusion, the 6-deoxy-α-L-taloside acceptor 14 was readily prepared in seven steps from methyl α-L-rhamnopyranoside in good overall yield. Glycosylation of 14 with the thiogalactoside donors 11 or 12 with NIS/TfOH as the promoter gave good yields of the α-linked disaccharide 22. Glycosylation with the thiomethyl donor 11 was preferred as it gave a cleaner reaction mixture from which the desired product was isolated in excellent yield. Glycosylation of 14 with the 2-azido-2-deoxy-glucosyl imidate 13 was not completely stereoselective (α:β = 6:1) and resulted in an inseparable mixture. However, deacetylation and conversion into the corresponding tribenzoates allowed for the isolation of the desired α-linked disaccharide 30 in good overall yield (60%). Unfortunately, the intermediates readily derived from 22 and 30 were not stable to the sulfonation/deacylation conditions required for their conversion into the target HS mimetics, resulting in complex mixtures from which no products could be isolated.

 Supplementary Materials

Supplementary materials can be accessed at: http://www.mdpi.com/1420-3049/17/8/9790/s1.

 Acknowledgments

We thank Siska Cochran, Caiping Li, Ian Bytheway and Robert Don for useful discussions.

 References Presta M. Dell’Era P. Mitola S. Moroni E. Ronca R. Rusnati M. Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis Cytokine Growth Factor Rev. 2005 16 159 178 10.1016/j.cytogfr.2005.01.004 Korc M. Friesel R.E. The role of fibroblast growth factors in tumor growth Curr. Cancer Drug Targets 2009 9 639 651 10.2174/156800909789057006 Eswarakumar V.P. Lax I. Schlessinger J. Cellular signaling by fibroblast growth factor receptors Cytokine Growth Factor Rev. 2005 16 139 149 10.1016/j.cytogfr.2005.01.001 Parish C.R. Freeman C. Brown K.J. Francis D.J. Cowden W.B. Identification of sulfated oligosaccharide-based inhibitors of tumor growth and metastasis using novel in vitro assays for angiogenesis and heparanase activity Cancer Res. 1999 59 3433 3441 10416607 Ferro V. Liu L. Johnstone K.D. Wimmer N. Karoli T. Handley P. Rowley J. Dredge K. Li C.P. Hammond E. Discovery of PG545: a highly potent and simultaneous inhibitor of angiogenesis, tumor growth, and metastasis J. Med. Chem. 2012 55 3804 3813 10.1021/jm201708h22458531 Casu B. Naggi A. Torri G. Heparin-derived heparan sulfate mimics to modulate heparan sulfate-protein interaction in inflammation and cancer Matrix Biol. 2010 29 442 452 10.1016/j.matbio.2010.04.003 Force T. Kolaja K.L. Cardiotoxicity of kinase inhibitors: The prediction and translation of preclinical models to clinical outcomes Nat. Rev. Drug Discov. 2011 10 111 126 10.1038/nrd3252 Angulo J. Ojeda R. de Paz J.L. Lucas R. Nieto P.M. Lozano R.M. Redondo-Horcajo M. Giménez-Gallego G. Martín-Lomas M. The activation of fibroblast growth factors (FGFs) by glycosaminoglycans: influence of the sulfation pattern on the biological activity of FGF-1 ChemBioChem 2004 5 55 61 10.1002/cbic.200300696 Poletti L. Lay L. Chemical contributions to understanding heparin activity: synthesis of related sulfated oligosaccharides Eur. J. Org. Chem. 2003 2999 3024 10.1002/ejoc.200200721 O’Brien A. Lynch C. O’Boyle K.M. Murphy P.V. Synthesis of disaccharides derived from heparin and evaluation of effects on endothelial cell growth and on binding of heparin to FGF-2 Carbohydr. Res. 2004 339 2343 2354 10.1016/j.carres.2004.07.01815388349 Canales A. Angulo J. Ojeda R. Bruix M. Fayos R. Lozano R. Gimenez-Gallego G. Martin-Lomas M. Nieto P.M. Jimenez-Barbero J. Conformational flexibility of a synthetic glycosylaminoglycan bound to a fibroblast growth factor. FGF-1 recognizes both the (1)C(4) and (2)S(O) conformations of a bioactive heparin-like hexasaccharide J. Am. Chem. Soc. 2005 127 5778 5779 10.1021/ja043363y15839662 Hung S.C. Lu X.A. Lee J.C. Chang M.D. Fang S.L. Fan T.C. Zulueta M.M. Zhong Y.Q. Synthesis of heparin oligosaccharides and their interaction with eosinophil-derived neurotoxin Org. Biomol. Chem. 2012 10 760 772 10.1039/c1ob06415k Tiruchinapally G. Yin Z.J. El-Dakdouki M. Wang Z. Huang X.F. Divergent heparin oligosaccharide synthesis with preinstalled sulfate esters Chem.-Eur. J. 2011 17 10106 10112 10.1002/chem.20110110821786352 Maza S. Macchione G. Ojeda R. Lopez-Prados J. Angulo J. de Paz J.L. Nieto P.M. Synthesis of amine-functionalized heparin oligosaccharides for the investigation of carbohydrate-protein interactions in microtiter plates Org. Biomol. Chem. 2012 10 2146 2163 10.1039/c2ob06607f22294265 Murphy P.V. Pitt N. O’Brien A. Enright P.M. Dunne A. Wilson S.J. Duane R.M. O’Boyle K.M. Identification of novel inhibitors of fibroblast growth factor (FGF-2) binding to heparin and endothelial cell survival from a structurally diverse carbohybrid library Bioorg. Med. Chem. Lett. 2002 12 3287 3290 10.1016/S0960-894X(02)00700-X Liu L. Li C.P. Cochran S. Ferro V. Application of the four-component Ugi condensation for the preparation of sulfated glycoconjugate libraries Bioorg. Med. Chem. Lett. 2004 14 2221 2226 10.1016/j.bmcl.2004.02.01715081013 Zhang J. Riverst G. Zhu Y. Jacobson A. Peyers J. Grundstrom G. Burch P. Hussein S. Marolewski A. Herlihy W. Rusche J. Identification of inhibitors of heparin-growth factor interactions from combinatorial libraries of four-component condensation reactions Bioorg. Med. Chem. 2001 9 825 836 10.1016/S0968-0896(00)00317-511354665 Liu L. Bytheway I. Karoli T. Fairweather J.K. Cochran S. Li C. Ferro V. Design, synthesis, FGF-1 binding, and molecular modeling studies of conformationally flexible heparin mimetic disaccharides Bioorg. Med. Chem. Lett. 2008 18 344 349 10.1016/j.bmcl.2007.10.071 Fairweather J.K. Karoli T. Liu L. Bytheway I. Ferro V. Synthesis of a heparan sulfate mimetic disaccharide with a conformationally locked residue from a common intermediate Carbohydr. Res. 2009 344 2394 2398 10.1016/j.carres.2009.09.01219819428 Pellegrini L. Role of heparan sulfate in fibroblast growth factor signalling: A structural view Curr. Opin. Struct. Biol. 2001 11 629 634 10.1016/S0959-440X(00)00258-X Ferro D.R. Provasoli A. Ragazzi M. Torri G. Casu B. Gatti G. Jacquinet J.C. Sinaÿ P. Petitou M. Choay J. Evidence for conformational equilibrium of the sulfated L-iduronate residue in heparin and in synthetic heparin mono- and oligosaccharides: NMR and force-field studies J. Am. Chem. Soc. 1986 108 6773 6778 10.1021/ja00281a052 Ferro D.R. Provasoli A. Ragazzi M. Casu B. Torri G. Bossennec V. Perly B. Sinaÿ P. Petitou M. Choay J. Conformer populations of L-iduronic acid residues in glycosaminoglycan sequences Carbohydr. Res. 1990 195 157 167 10.1016/0008-6215(90)84164-P Probst K.C. Wessel H.P. Synthesis and conformational investigations of sulfated carbohydrates J. Carbohydr. Chem. 2001 20 549 560 10.1081/CAR-100108273 Wessel H.P. Bartsch S. Conformational flexibility in highly sulfated -β-D-glucopyranoside derivatives Carbohydr. Res. 1995 274 1 9 10.1016/0008-6215(95)00131-C DiGabriele A.D. Lax I. Chen D.I. Svahn C.M. Jaye M. Schlessinger J. Hendrickson W.A. Structure of a heparin-linked biologically active dimer of fibroblast growth factor Nature 1998 393 812 817 10.1038/317419655399 Faham S. Hileman R.E. Fromm J.R. Linhardt R.J. Rees D.C. Heparin structure and interactions with basic fibroblast growth factor Science 1996 271 1116 1120 10.1126/science.271.5252.11168599088 Clode D.M. Horton D. Weckerle W. Reaction of derivatives of methyl 2,3-O-benzylidene-6-deoxy-α-L-mannopyranoside with butyllithium: Synthesis of methyl 2,6-dideoxy-4-O-methyl-α-L-erythro-hexopyranosid-3-ulose Carbohydr. Res. 1976 49 305 314 10.1016/S0008-6215(00)83147-X Petit E. Papy-Garcia D. Muller G. Courtois B. Caruelle J.-P. Courtois J. Controlled sulfatation of natural anionic bacterial polysaccharides can yield agents with specific regenerating activity in vivo Biomacromolecules 2004 5 445 452 10.1021/bm034257b15003004 Cui J.-F. Byström S. Eneroth P. Björkhem I. Novel mechanism for oxidative cleavage of glycosidic bonds: evidence for an oxygen dependent reaction J. Org. Chem. 1994 59 8251 8255 10.1021/jo00105a050 Lai Y.Z. Kinetic evidence of anionic intermediates in the base-catalyzed cleavage of glycosidic bonds in the methyl D-glucopyranosides Carbohydr. Res. 1972 24 57 65 10.1016/S0008-6215(00)82259-4 Orgueira H.A. Bartolozzi A. Schell P. Litjens R.E.J.N. Palmacci E.R. Seeberger P.H. Modular synthesis of heparin oligosaccharides Chem. Eur. J. 2003 9 140 169 10.1002/chem.200390009 Farndale R.W. Buttle D.J. Barrett A.J. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue Biochim. Biophys. Acta 1986 883 173 177 10.1016/0304-4165(86)90306-5 Yu G. Gunay N.S. Linhardt R.J. Toida T. Fareed J. Hoppensteadt D.A. Shadid H. Ferro V. Li C. Fewings K. Preparation and anticoagulant activity of the phosphosulfomannan PI-88 Eur. J. Med. Chem. 2002 37 783 791 10.1016/S0223-5234(02)01347-812446036 Pozsgay V. Trinh L. Shiloach J. Robbins J.B. Donohue-Rolfe A. Calderwood S.B. Purification of subunit B of Shiga toxin using a synthetic trisaccharide-based affinity matrix Bioconjug. Chem. 1996 7 45 55 10.1021/bc95007118741990 Lipták A. Imre J. Nánási P. Preparation of carbohydrate isopropylidene derivatives with 2,2-dimethoxypropane in the presence of toluene-p-sulphonic acid Carbohydr. Res. 1981 92 154 156 10.1016/S0008-6215(00)85991-1 Bajza I. Kövér K.E. Lipták A. Synthesis of p-trifluoroacetamidophenyl (4,6-dideoxy-4-formamido-3-C-methyl-2-O-methyl-α-L-mannopyranosyl)- (1→3)-(2-O-methyl-α-D-rhamnopyranosyl)-(1→3)- (2-O-methyl-α-L-fucopyranosyl)-(1→3)-(α-L-rhamnopyranosyl)- (1→2)-6-deoxy-α-L-talopyranoside: A spacer-armed pentasaccharide glycopeptidolipid antigen of Mycobacterium avium serovar 14 Carbohydr. Res. 1998 308 247 258 10.1016/S0008-6215(98)00074-3

Sample Availability: Not available.